Health and Human Services Secretary and long-time vaccine critic Robert F. Kennedy Junior’s decision to cancel $500 million ...

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on ...

Fewer Kentucky kindergarten students have received the vaccines required to attend school, and data from the state's School ...

Hawaii’s COVID-19 cases are still ticking up, continuing an upward trend that began this summer. A scientific expedition off the west coast of Hawaii Island has concluded a two-we... A Keaau couple ...

Variant XFG, colloquially known as "Stratus," was first detected in Southeast Asia in January but accounted for less than ...

Notably, Pfizer's Comirnaty COVID vaccine is still approved or authorized for people 6 months of age and older without any ...

It’s been five years since the coronavirus outbreak, and while vaccines have made things safer for those more vulnerable, Covid is still something we ought to look out for and be made aware of. The ...

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain’s GSK and Germany’s CureVac $740 million plus royalties to settle US legal disputes over Covid-19 vaccines, ...

Robert F. Kennedy Jr., the HHS Secretary of the US, despite a long history of the contray, now often pretends to be not against vaccinations. Yet, his recent actions depict an entirely different ...

On Wednesday, after the news that the HHS was terminating crucial vaccine development projects worth $500 million, Cassidy called the decision "unfortunate" in a post on the X social network. That’s a ...

GSK said it would receive $370 million as part of a U.S. patent settlement between CureVac and BioNTech related to messenger mRNA-based Covid-19 vaccines.